Tuesday, 30 May 2023 01:30 AM
Class Action
NEW YORK, NY / ACCESSWIRE / May 30, 2023 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Allbirds, Inc. (NASDAQ: BIRD)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/allbirds-class-action-submission-form?prid=40009&wire=1
Lead Plaintiff Deadline: June 12, 2023
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Allbirds Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's November 2021 initial public offering; and/or (b) Allbirds securities between November 4, 2021 and March 9, 2023, inclusive.
Allegations against BIRD include that: (1) Allbirds was overemphasizing products that extended beyond the Company's core offerings; (2) the Company's non-core products had a narrower appeal and were not resonating with customers as well as the Company's core products; (3) Allbirds was underinvesting in its core consumers' favorite products to push the Company's newer products with narrower appeal; (4) underinvesting in Allbirds' core products was negatively impacting the Company's sales; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Horizon Bancorp, Inc. (NASDAQ: HBNC)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/horizon-class-action-submission-form?prid=40009&wire=1
Lead Plaintiff Deadline: June 20, 2023
Class Period: March 9, 2022 - March 10, 2023
Allegations against HBNC include that: (i) the Company maintained deficient internal accounting controls relating to its classification of certain loan balances and securities; (ii) as a result of the foregoing deficiencies, throughout 2022 the Company issued quarterly financial statements containing errors that would require subsequent revision; (iii) restatement of the foregoing financial statements would hinder the Company's ability to timely file its annual report for 2022; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Charles River Laboratories International, Inc. (NYSE: CRL)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/charles-river-class-action-submission-form?prid=40009&wire=1
Lead Plaintiff Deadline: July 18, 2023
Class Period: May 5, 2020 - February 21, 2023
Allegations against CRL include that: (1) Charles River had engaged in illegal activity with respect to its importation of non-human primates for research; (2) as a result, Charles River was at a heightened risk of criminal and regulatory investigation by, inter alia, the U.S. Department of Justice; (3) as a result, Charles River would be forced to suspend shipments of primates from Cambodia; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
To learn more contact Vincent Wong, Esq. either via email [email protected] or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: [email protected]
SOURCE : The Law Offices of Vincent Wong